Allele is focused on implementing transformative innovations in the point-of-care diagnostics field by creating accurate, effective devices that are more accessible than current market products. When investigating revolutionary devices for pressing global health concerns, Allele emphasizes accuracy and attainability: cutting-edge technology that provides results in minutes, at a fraction of the cost of current diagnostic methods. Learn More News Featured Aug. 11, 2022 Allele Inc. Files Patent Application for Gradient Lateral Flow Assay Devices Aug. 11, 2022 Read More → Aug. 11, 2022 Apr. 4, 2022 Allele Inc. Files Patent Application for Nanoparticles conjugated to specific Nucleotide Sequences Apr. 4, 2022 Read More → Apr. 4, 2022